Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 56% ± 17% |
Insufficient scRNA-seq data for expression of SLC22A7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 25175.92 | 226 / 226 | 91% | 190.84 | 369 / 406 |
kidney | 100% | 4487.83 | 89 / 89 | 44% | 5.85 | 396 / 901 |
brain | 92% | 38.92 | 2431 / 2642 | 1% | 0.02 | 8 / 705 |
spleen | 79% | 35.59 | 190 / 241 | 0% | 0 | 0 / 0 |
prostate | 78% | 16.11 | 191 / 245 | 0% | 0 | 0 / 502 |
heart | 59% | 22.99 | 512 / 861 | 0% | 0 | 0 / 0 |
ovary | 44% | 4.59 | 79 / 180 | 0% | 0.01 | 2 / 430 |
uterus | 37% | 4.78 | 63 / 170 | 1% | 0.03 | 3 / 459 |
skin | 34% | 4.52 | 614 / 1809 | 1% | 0.01 | 3 / 472 |
intestine | 34% | 4.06 | 330 / 966 | 0% | 0.25 | 2 / 527 |
peripheral blood | 34% | 5.56 | 315 / 929 | 0% | 0 | 0 / 0 |
bladder | 29% | 2.67 | 6 / 21 | 0% | 0.00 | 1 / 504 |
thymus | 25% | 3.22 | 165 / 653 | 0% | 0.00 | 1 / 605 |
esophagus | 23% | 2.78 | 335 / 1445 | 2% | 0.06 | 3 / 183 |
adrenal gland | 21% | 2.90 | 53 / 258 | 0% | 0 | 0 / 230 |
adipose | 17% | 4.50 | 209 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 16% | 1.87 | 53 / 328 | 1% | 0.03 | 2 / 178 |
stomach | 15% | 1.45 | 54 / 359 | 2% | 0.03 | 6 / 286 |
breast | 15% | 3.02 | 70 / 459 | 0% | 0.01 | 5 / 1118 |
lung | 11% | 1.34 | 63 / 578 | 1% | 0.02 | 10 / 1155 |
blood vessel | 10% | 1.36 | 133 / 1335 | 0% | 0 | 0 / 0 |
muscle | 5% | 0.51 | 44 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006811 | Biological process | monoatomic ion transport |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0015732 | Biological process | prostaglandin transport |
GO_0015742 | Biological process | alpha-ketoglutarate transport |
GO_0015711 | Biological process | organic anion transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0015139 | Molecular function | alpha-ketoglutarate transmembrane transporter activity |
GO_0015132 | Molecular function | prostaglandin transmembrane transporter activity |
GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
GO_0015347 | Molecular function | sodium-independent organic anion transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0022857 | Molecular function | transmembrane transporter activity |
Gene name | SLC22A7 |
Protein name | Solute carrier family 22 member 7 SLC22A7 protein (Solute carrier family 22 (Organic anion transporter), member 7, isoform CRA_d) Solute carrier family 22 member 7 (Novel liver transporter) (NLT) (Organic anion transporter 2) (hOAT2) |
Synonyms | NLT OAT2 hCG_19011 |
Description | FUNCTION: [Isoform 2]: Functions as a Na(+)-independent bidirectional multispecific transporter . Contributes to the renal and hepatic elimination of endogenous organic compounds from the systemic circulation into the urine and bile, respectively . Capable of transporting a wide range of purine and pyrimidine nucleobases, nucleosides and nucleotides, with cGMP, 2'deoxyguanosine and GMP being the preferred substrates . Functions as a pH- and chloride-independent cGMP bidirectional facilitative transporter that can regulate both intracellular and extracellular levels of cGMP and may be involved in cGMP signaling pathways . Mediates orotate/glutamate bidirectional exchange and most likely display a physiological role in hepatic release of glutamate into the blood . Involved in renal secretion and possible reabsorption of creatinine . Able to uptake prostaglandin E2 (PGE2) and may contribute to PGE2 renal excretion (Probable). Also transports alpha-ketoglutarate and urate . Apart from the orotate/glutamate exchange, the counterions for the uptake of other SLC22A7/OAT2 substrates remain to be identified . .; FUNCTION: [Isoform 1]: Non functional transporter. .; FUNCTION: [Isoform 3]: Involved in the uptake of prostaglandin F2-alpha (PGF2-alpha). . |
Accessions | X6RDF7 ENST00000372585.10 [Q9Y694-1] Q9Y694 Q5T051 ENST00000372574.7 [Q9Y694-3] Q8WWC3 Q5T047 ENST00000436107.1 ENST00000372589.7 [Q9Y694-2] ENST00000451757.5 ENST00000449231.5 |